New $39 million government funding to improve access to HIV treatment

People without Medicare can now access government-funded HIV treatment, after a $39 million investment from the federal government.

New $39 million government funding to improve access to HIV treatment

Image Credit: ASHM

Under the new funding model, people with HIV without Medicare will access free or subsidized treatment from hospital pharmacies or sexual health clinics, depending on which state or territory they live in.

Previously, people with HIV without Medicare accessed treatment through an industry-sponsored compassionate access scheme.

To ensure medical professionals understand what these changes mean and how to provide accurate information and advice to clients, ASHM has released state-specific webinars and online resources on these new protocols.

ASHM CEO Alexis Apostolellis said that it’s crucial we equip doctors, nurses, pharmacists, community health workers and sexual health workers with the information they need to realize these significant changes.

These new arrangements will increase access to treatment for hundreds of people with HIV in Australia a significant step towards achieving Australia’s goal of ending HIV transmission by 2030. To seamlessly and effectively implement these changes, we need to make sure medical professionals are aware of them – so they clearly understand what this means for their clients.”

Alexis Apostolellis, CEO, ASHM

Greater access to treatment for people with HIV in Australia without Medicare will improve health outcomes for individuals, while decreasing transmission of HIV, and working towards the goal of ending HIV transmission by 2030.

All Australian states and territories have now signed on to the new scheme.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug